Nature Communications (Aug 2018)

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

  • Jingying Nong,
  • Yuhua Gong,
  • Yanfang Guan,
  • Xin Yi,
  • Yuting Yi,
  • Lianpeng Chang,
  • Ling Yang,
  • Jialin Lv,
  • Zhirong Guo,
  • Hongyan Jia,
  • Yuxing Chu,
  • Tao Liu,
  • Ming Chen,
  • Lauren Byers,
  • Emily Roarty,
  • Vincent K. Lam,
  • Vassiliki A. Papadimitrakopoulou,
  • Ignacio Wistuba,
  • John V. Heymach,
  • Bonnie Glisson,
  • Zhongxing Liao,
  • J. Jack Lee,
  • P. Andrew Futreal,
  • Shucai Zhang,
  • Xuefeng Xia,
  • Jianjun Zhang,
  • Jinghui Wang

DOI
https://doi.org/10.1038/s41467-018-05327-w
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 8

Abstract

Read online

Small cell lung cancer (SCLC) may evolve under treatment. But tumor tissues are often not available to study evolution of SCLC. Here, the authors utilize circulating tumor DNA to investigate the genomic evolution and subclonal architecture of SCLC during therapy.